Viewing data from:

VASOPRESSIN

ANDA

VASOPRESSIN | A211857 | AMPHASTAR PHARMACEUTICALS INC

1 strength0 unique patents0 unique exclusivities

Reference Listed Drug: VASOSTRICT(TE code: AP)

Hatch-Waxman Litigation

1 case on OB patents from PACER

Case	Court	Filed	Status	Judge
Par Pharmaceutical, Inc. et al v. Amneal Pharmaceuticals of New York, LLC, et al., 1:2018cv02032 6 patentsANDA 211857Vasopressin	D. Del.	2018-12-20	Terminated 2022-02-09	—

Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).

VA Federal Supply Schedule

Government-negotiated contract prices | 1 NDC (1 FSS)

Lowest Price

$269.35

Highest Price

$269.35

FSS NDCs

Big4 NDCs

Description	Price	Type	Vendor	Contract End
00548-9701-00VASOPRESSIN 20UNT/ML INJ	$269.35	FSS	Amphastar Pharmaceuticals, Inc.	01/14/2027

Source: VA Federal Supply Schedule (va.gov). Prices are government-negotiated contract prices.

API Supply Chain8 active DMFs1 inactive

8 active API suppliers hold Drug Master Files for this ingredient.

BCN PEPTIDES SAVASOPRESSIN

DMF 257362012

BACHEM AMERICAS INCVASOPRESSIN, USP (BULK)

DMF 285322014

POLYPEPTIDE LABORATORIES SWEDEN ABVASOPRESSIN

DMF 321162017

PIRAMAL PHARMA LTDVASOPRESSIN USP

DMF 321462017

INTERNATIONAL MEDICATION SYSTEMS LTDVASOPRESSIN USP

DMF 327692018

AURO PEPTIDES LTDVASOPRESSIN USP

DMF 331192018

HAINAN SHUANGCHENG PHARMACEUTICALS CO LTDVASOPRESSIN USP

DMF 376342022

HETERO DRUGS LTDVASOPRESSIN USP

DMF 420732025

POLYPEPTIDE LABORATORIES SWEDEN ABInactiveVASOPRESSIN

DMF 275772013

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Approval Letters

1 letter from Drugs@FDA

Date	Submission	Document
Jan 12, 2022	ORIG -1	View Letter (PDF)

Source: Drugs@FDA application documents.

Products (1)

#001 — 20UNITS/ML (20UNITS/ML)

0 patents0 exclusivities▴

SOLUTION;INTRAVENOUS | Approved: Jul 18, 2022

No patent or exclusivity listings for this strength.